A. Fernandes et al. / Tetrahedron Letters 49 (2008) 3484–3488
3487
22.7, 26.2, 29.1, 29.5, 31.8 (heptyl CH2), 36.4 (C-2), 61.2 (C-8), 62.4
(C-5), 67.7 (C-9), 68.8 (C-6), 72.5 (PhCH2O), 72.8 (C-3), 83.7 (C-4),
96.9 (C-7), 97.9 (C-1), 127.6–129.2 (CH-Ar), 133.9 (CH-para-PhSO2),
138.8 (CIV-Ar), 139.9 (CIV-PhSO2). MS (IS) m/z = 519.5 [M+H]+,
542.5 [M+Na]+.
Acknowledgements
The authors would like to thank Professor D. Sinou and
Dr. P. Lhoste for helpful discussions and a generous gift of
´
´
compound 16, the CNRS and the Universite d’Orleans for
financial support.
10. 1,5-Anhydro-2,3-dideoxy-4,6-O-(2-phenylsulfonyl)ethylidene-D-erythro-
20
hex-2-enitol 12: Syrup; ½aꢃD +1 (c = 0.4, CHCl3). 1H NMR (250 MHz,
CDCl3): d = 3.25 (ddd, 1H, J5–6b = 10.3 Hz, J5–6a = 4.8 Hz, J4–5
=
8.3 Hz, H-5), 3.48 (d, 2H, J7–8 = 5.0 Hz, H-8a, H-8b), 3.53 (t, 1H,
J5–6b = J6a–6b = 10.3 Hz, H-6b), 3.92–3.95 (m, 1H, H-4), 4.06 (dd, 1H,
J5–6a = 4.8, H-6a), 4.18–4.21 (m, 2H, H-1a, H-1b), 5.11 (t,
1H, J7–8 = 5.0 Hz, H-7), 5.63 (d, 1H, J2–3 = 10.5 Hz, H-2), 5.70 (dt,
1H, J3–1 = J3–4 = 1.8 Hz, J3–2 = 10.5 Hz, H-3), 7.53–7.59 (m, 2H,
meta-H–PhSO2), 7.64–7.69 (m, 1H, para-H–PhSO2), 7.91 (d, 2H,
J = 7.3, ortho-H–PhSO2). 13C NMR (62.5 MHz, CDCl3): d = 60.1
(C-8), 66.5 (C-1), 69.2 (C-6), 69.7 (C-5), 75.0 (C-4), 97.0 (C-7), 125.3
(C-2), 127.9 (C-3), 128.4 (CH-ortho-PhSO2), 129.1 (CH-meta-PhSO2),
133.9 (CH-para-PhSO2), 139.9 (CIV-PhSO2). MS (IS) m/z = 314
[M+NH4]+, 319 [M+Na]+.
References and notes
1. (a) Haines, A. H. Adv. Carbohydr. Chem. Biochem. 1981, 39, 13–
70; (b) Gelas, J. Adv. Carbohydr. Chem. Biochem. 1981, 39, 71–
156.
´
2. (a) Chery, F.; Rollin, P.; De Lucchi, O.; Cossu, S. Tetrahedron Lett.
´
2000, 41, 2357–2360; (b) Chery, F.; Rollin, P.; De Lucchi, O.; Cossu,
S. Synthesis 2001, 286–292.
3. Cabianca, E.; Tatiboue¨t, A.; Rollin, P. Pol. J. Chem. 2005, 79, 317–
322.
3-O-Acetyl-1,5-anhydro-2-deoxy-4,6-O-(2-phenylsulfonyl)ethylidene-
20
4. Chevalier-du Roizel, B.; Cabianca, E.; Rollin, P.; Sinay, P. Tetra-
¨
D-glucitol 11: Syrup; ½aꢃD +3 (c = 1.0, CHCl3). 1H NMR (250 MHz,
hedron 2002, 58, 9579–9583.
CDCl3): d = 1.63–1.75 (m, 2H, H-2), 2.08–2.17 (m, 4H, H-2, MeCO),
3.21 (dd, 1H, J5–6b = 9.5 Hz, J4–5 = 4.8 Hz, H-5), 3.39–3.57 (m, 3H,
H-1ax, H-4, H-6b), 3.47 (d, 2H, J7–8 = 4.8 Hz, H-8a, H-8b), 3.92 (dd,
5. (a) Ferrier, R. J. Top. Curr. Chem. 2001, 215, 153–175; (b) Procopio,
A.; Dalpozzo, R.; De Nino, A.; Maiuolo, L.; Nardi, M.; Oliverio, M.;
Russo, B. Carbohydr. Res. 2007, 342, 2125–2131; (c) Rauter, A. P.;
Almeida, T.; Xavier, N. M.; Siopa, F.; Vicente, A. I.; Lucas, S. D.;
Marques, J. P.; Ribeiro, F. R.; Guisnet, M.; Ferreira, M. J. J. Mol.
Catal., A: Chem. 2007, 275, 206–213; (d) Kim, H.; Men, H.; Lee, C. J.
Am. Chem. Soc. 2004, 126, 1336–1337; (e) Hotha, S.; Tripathi, A. J.
Comb. Chem. 2005, 7, 968–976.
6. (a) Marzabadi, C. H.; Franck, R. W. Tetrahedron 2000, 56, 8345–
8417; (b) Catelani, G.; Colonna, F.; Rollin, P. Gazz. Chim. Ital. 1989,
119, 389–393; (c) Rauter, A. P.; Almeida, T.; Vicente, A. I.; Ribeiro,
V.; Bordado, J. C.; Marques, J. P.; Ribeiro, F. R.; Ferreira, M. J.;
Oliveira, C.; Guisnet, M. Eur. J. Org. Chem. 2006, 2429–2439; (d)
Sherry, B. D.; Loy, R. N.; Toste, F. D. J. Am. Chem. Soc. 2004, 126,
4510–4511; (e) Colinas, P. A.; Bravo, R. D. Org. Lett. 2003, 5, 4509–
4511; (f) Gopal Reddy, B.; Madhusudanan, K. P.; Vankar, Y. D. J.
Org. Chem. 2004, 69, 2630–2633; (g) Yadav, J. S.; Subba Reddy, B.
V.; Vijaya Bhasker, E.; Raghavendra, S.; Narsaiah, A. V. Tetrahedron
Lett. 2007, 48, 677–680.
1H, J1a–b = 12.0 Hz, J1–2 = 4.5 Hz, H-1eq), 4.04 (dd, 1H, J6a–b
=
10.5 Hz, J5–6a = 5.0 Hz, H-6a), 4.88 (ddd, 1H, J3–4 = 10.8 Hz,
J2ax–3 = 9.5 Hz, J2eq–3 = 5.4 Hz, H-3), 5.08 (t, 1H, J 7–8 = 4.8 Hz,
H-7), 7.52–7.58 (m, 2H, meta-H–PhSO2), 7.63–7.68 (m, 1H, para-H–
PhSO2) 7.91 (d, 2H, J = 7.3 Hz, ortho-H–PhSO2). 13C NMR
(62.5 MHz, CDCl3): d = 21.3 (MeCO), 31.5 (C-2), 60.1 (C-8), 66.1
(C-6), 68.5 (C-1), 70.6 (C-3), 71.4 (C-5), 80.4 (C-4), 96.9 (C-7), 128.3
(CH-ortho-PhSO2), 129.2 (CH-meta-PhSO2), 134.0 (CH-para-PhSO2),
140.1 (CIV-PhSO2), 170.5 (CO). MS (IS) m/z = 357.5 [M+H]+, 374.5
[M+NH4]+, 379.5 [M+Na]+.
(1R)-1-C-Allyl-1,5-anhydro-2,3-dideoxy-4,6-O-(2-phenylsulfonyl)-
20
ethylidene-D-erythro-hex-2-enitol 13: Syrup; ½aꢃD +6 (c 1.1, CHCl3).
1H NMR (250 MHz, CDCl3): d = 2.17–2.45 (m, 2H, allyl CH2), 3.32
(ddd, 1H, J5–6b = 10.1 Hz, J4–5 = 8.3 Hz, J5–6a = 4.8 Hz, H-5), 3.47–
3.60 (m, 1H, H-6b), 3.48 (d, 2H, J7–8 = 4.8 Hz, H-8a, H-8b), 3.85 (dd,
1H, J4–5 = 8.3 Hz, J1–4 = 2.0 Hz, H-4), 4.02 (dd, 1H, J6a–b = 10.3 Hz,
J5–6a = 4.8 Hz, H-6a), 4.23 (td, J1-CH ¼ J1-CH ¼ 6:3 Hz, J1–4
=
7. (a) Seeberger, P. H.; Roehrig, S.; Schell, P.; Wang, Y.; Christ, W. J.
Carbohydr. Res. 2000, 328, 61–69; (b) Geiger, J.; Barroca, N.;
Schmidt, R. R. Synlett 2004, 836–840.
2
2
2.5 Hz, H-1), 5.04–5.11 (m, 3H, H-7, @CH2), 5.63–5.87 (m, 3H,
H-2, H-3, @CH), 7.53–7.59 (m, 2H, meta-H–PhSO2), 7.63–7.69 (m,
1H, para-H–PhSO2), 7.91 (1H, d, J = 7.3 Hz, ortho-H–PhSO2). 13C
NMR (62.5 MHz, CDCl3): d = 38.3 (allyl CH2), 60.2 (C-8), 65.0
(C-5), 69.5 (C-6), 73.9 (C-1), 75.0 (C-4), 97.0 (C-7), 117.8 (@CH2),
126.1 (C-2), 128.5 (CH-ortho-PhSO2), 129.1 (CH-meta-PhSO2), 130.6
(C-3), 133.9 (CH-para-PhSO2), 134.2 (@CH), 139.9 (CIV-PhSO2). MS
(IS) m/z = 337.5 [M+H]+, 354.5 [M+NH4]+, 359.5 [M+Na]+.
3-O-Acetyl-2-deoxy-4,6-O-(2-phenylsulfonyl)ethylidene-a-D-arabino-
´
8. Strong bases readily induce ring opening of PSE acetals: Chery, F.;
Tatiboue¨t, A.; De Lucchi, O.; Rollin, P., unpublished results.
9. Representative procedure: PSE-glucal 2 or 3a (0.1 g) was dissolved in
˚
DCM (4 mL) under argon. Activated 3 A molecular sieves (0.2 g)
were added, followed by the nucleophile; the resulting slurry was then
cooled to 0 °C and stirred for 1 h. TMSOTf (1.2 equiv) was added and
the reaction allowed to warm up slowly to room temperature. At the
end of the reaction, the solution was quickly filtered over a MgSO4
pad, then diluted with EtOAc (40 mL) and washed with water
(3 ꢂ 20 mL) then brine (20 mL). The organic solution was dried over
MgSO4, evaporated under reduced pressure and purified by silica gel
chromatography (petroleum-ether–AcOEt elution).
20
hexopyranosyl azide 14a: Syrup; ½aꢃD +24 (c 1.0, CHCl3). 1H NMR
(250 MHz, CDCl3): d = 1.74 (ddd, 1H, J2ax–2eq = 13.4 Hz, J2ax–3
=
11.3 Hz,J1–2ax = 4.5 Hz, H-2ax), 2.10 (s, 3H, MeCO), 2.19 (dd, 1H,
J2eq–3 = 5.3 Hz, J1–2eq = 1.0 Hz, H-2eq), 3.43–3.57 (m, 2H, H-4,
H-6b), 3.48 (d, 2H, J7–8 = 4.8 Hz, H-8a, H-8b), 3.78 (dd, 1H, J4–5
=
10.0 Hz, J5–6 = 5.0 Hz, H-5), 4.06 (dd, 1H, J6a–b = 10.3 Hz,
J5–6a = 4.8 Hz, H-6a), 5.03–5.15 (m, 2H, H-3, H-7), 5.42 (d, 1H,
J1–2ax = 4.5 Hz, H-1), 7.52–7.58 (m, 2H, meta-H–PhSO2), 7.63–7.69
(m, 1H, para-H–PhSO2), 7.91 (d, 1H, J = 7.0 Hz, ortho-H–PhSO2).
13C (62.5 MHz, CDCl3): d = 21.2 (MeCO), 34.8 (C-2), 60.0 (C-8), 64.6
(C-5), 66.8 (C-3), 68.3 (C-6), 79.9 (C-4), 87.2 (C-1), 97.0 (C-7), 128.2
(CH-ortho-PhSO2), 129.2 (CH-meta-PhSO2), 134.0 (CH-para-PhSO2),
140.0 (CIV-PhSO2), 170.0 (CO). MS (IS) m/z = 398.5 [M+H]+, 415.5
[M+NH4]+, 420.5 [M+Na]+.
Selected analytical data for n-heptyl 3-O-benzyl-2-deoxy-4,6-O-(2-
phenylsulfonyl)ethylidene-a-D-arabino-hexopyranoside 10b: Syrup;
20
½aꢃD +54 (c = 2.1, CHCl3). 1H NMR (400 MHz, CDCl3): d = 0.80
(3H, m, Me), 1.20 (br s, 8H, heptyl CH2), 1.45 (m, 2H, heptyl CH2),
1.62 (ddd, 1H, H-2ax), 2.13 (dd, 2H, J2a–b = 13.3 Hz, H-2eq), 3.22 (dt,
1H, Jgem = 9.6 Hz, Jvic = 4.8 Hz, H-9b), 3.33–3.56 (m, 6H, H-4, H-5,
H-6b, H-8a, H-8b, H-9a), 3.78 (ddd, 1H, J3,4 = 9.1 Hz,
J3,2eq = 5.0 Hz, J3,2ax = 11.1 Hz, H-3), 3.92 (dd, 1H, J6a,6b = 10.2 Hz,
J6a,5 = 4.7 Hz, H-6a), 4.48 and 4.62 (2d, AB system, 2H,
Jgem = 11.9 Hz, PhCH2O), 4.74 (d, 1H, J1,2ax = 3.2 Hz, H-1), 4.97
(t, 1H, J7–8 = 5.1 Hz, H-7), 7.17–7.25 (m, 5H, H–Ph), 7.40–7.42 (m,
2H, meta-H–PhSO2), 7.50–7.54 (m, 1H, para-H–PhSO2) 7.83–7.86 (d,
2H, ortho-H–PhSO2). 13C NMR (100 MHz, CDCl3): d = 14.2 (Me),
3-O-Acetyl-2-deoxy-4,6-O-(2-phenylsulfonyl)ethylidene-a-D-arabino-
20
hexopyranosyl azide 14b: Syrup; ½aꢃD ꢀ25 (c 1.1, CHCl3). 1H NMR
(250 MHz, CDCl3): d = 1.51–1.65 (m, 1H, H-2ax), 2.09 (s, 3H,
MeCO), 2.34 (ddd, 1H, J2ax–2eq = 13.0 Hz, J2eq–3 = 5.3 Hz, J1–2eq
=